NLS Pharmaceutics (NLSP) Financial Statements

NLS Pharmaceutics's market cap is currently ―. The company's EPS TTM is $-0.189; its P/E ratio is ―; NLS Pharmaceutics is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.